A report released at the 2026 Brain-Computer Interface Conference in Beijing
said China’s industry is concentrated in the Beijing-Tianjin-Hebei region, the
Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, with an
emerging innovation-to-manufacturing ecosystem. Global brain-computer interface
companies numbered 1,175 in 2026, rising rapidly from 2025, as the industry
faces a reshuffling. China and the United States are competing for influence
across technology, applications, ecosystems and governance. Industry revenue is
concentrated in research and healthcare, while many medical devices remain in
development, clinical trials or regulatory review. Non-medical applications are
at an early stage, with scope for growth in human-computer interaction and
consumer electronics.